Gateway Advisory »

Neurocrine Biosciences shares owned by Gateway Advisory

Quarter-by-quarter ownership of Neurocrine Biosciences (NBIX) shares owned by Gateway Advisory from 13F filings

Historical chart of Gateway Advisory investment in Neurocrine Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Neurocrine Biosciences held by Gateway Advisory consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neurocrine Biosciences by Gateway Advisory

Quarter filed Position value Share count Share price at filing
2023-12-31 $298k 2.3k 131.76
2023-09-30 $260k 2.3k 112.50
2013-12-31 $103k 11k 9.36

More positions owned by Gateway Advisory

Ishares Tr Short Treas Bd (SHV)
Ishares Tr Ibonds Dec 2033 (IBDY)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Ishares Tr Ibonds Dec 2031 (IBDW)
Ishares Tr Ibonds Dec 2032 (IBDX)
Ishares Tr Ibonds Dec 2030 (IBDV)
Ishares Tr Ibonds Dec 29 (IBDU)
Ishares Tr Ibds Dec28 Etf (IBDT)
Invesco Exchange Traded Fd T Dorsey Wright Mo (PDP)
Ishares Tr Ibonds 27 Etf (IBDS)
Ishares Jp Mrgn Em Hi Bd (EMHY)
Apple (AAPL)
Ishares Tr Ishares Biotech (IBB)
Ishares Tr Ibonds Dec2026 (IBDR)
Vaneck Etf Trust Long Muni Etf (MLN)

View all positions for Gateway Advisory

Top funds holding Neurocrine Biosciences

Vanguard Group
Bellevue Group
Jpmorgan Chase & Co
Henderson Group
T. Rowe Price Associates
Point72 Asset Management
Dodge & Cox
DSM Capital Partners
Wellington Management Company
Brown Advisory Holdings Incorporated
Bank of New York Mellon
Deerfield Management Company
Franklin Resources
Jacobs Levy Equity Management
AQR Capital Management

View all funds holding Neurocrine Biosciences